These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8190146)

  • 1. More on zidovudine in asymptomatic HIV infection.
    Altman DG; Cuzick J; Peto J
    N Engl J Med; 1994 Jun; 330(24):1758-9. PubMed ID: 8190146
    [No Abstract]   [Full Text] [Related]  

  • 2. Early zidovudine and survival in HIV infection.
    Gail MH; Mark SD
    N Engl J Med; 1992 Sep; 327(11):815; author reply 815-6. PubMed ID: 1472233
    [No Abstract]   [Full Text] [Related]  

  • 3. Zidovudine in asymptomatic HIV infection.
    N Engl J Med; 1990 Sep; 323(11):754-6. PubMed ID: 2388674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Zidovudine in asymptomatic HIV infection].
    Bornkessel B
    Med Monatsschr Pharm; 1991 Aug; 14(8):250. PubMed ID: 1921844
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine in asymptomatic HIV infection.
    Phillips AN; Sabin CA
    N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 8247049
    [No Abstract]   [Full Text] [Related]  

  • 6. Zidovudine in asymptomatic HIV infection.
    Martinez R
    N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 7902535
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term zidovudine therapy in patients with AIDS and symptomatic and asymptomatic HIV infection.
    Ebert S; Gockel K; Horowitz S; Weber P; Vogelman B; Graziano F
    Wis Med J; 1991 Apr; 90(4):161-5. PubMed ID: 1675028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine in asymptomatic HIV infection.
    Berger PB
    N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 7902534
    [No Abstract]   [Full Text] [Related]  

  • 9. A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.
    Peto TE
    AIDS; 1990; 4 Suppl 1():S187-91. PubMed ID: 2152565
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-retroviral therapy of HIV-infection. With preliminary results of the Swiss postmarketing surveillance of zidovudine].
    Jost J; Lüthy R
    Schweiz Med Wochenschr; 1991 Apr; 121(16):555-65. PubMed ID: 1904164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p24 antigenaemia as a predictor of good immunological responsiveness to zidovudine therapy in asymptomatic HIV infection.
    Montroni M; Silvestri G; Butini L; Bartocci C; Regnery C; Danieli G
    AIDS; 1992 Mar; 6(3):338-9. PubMed ID: 1567584
    [No Abstract]   [Full Text] [Related]  

  • 13. [Zidovudine for asymptomatic HIV patients?].
    Flepp M
    Dtsch Med Wochenschr; 1994 Oct; 119(40):1374-5. PubMed ID: 7924945
    [No Abstract]   [Full Text] [Related]  

  • 14. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early or asymptomatic HIV infection. Where are we and where do we go from here?
    Sacks HS
    Online J Curr Clin Trials; 1993 Oct; Doc No 93():[898 words; 7 paragraphs]. PubMed ID: 8306016
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Rooney J; Meng TC; Fischl MA; Collier AC; Phair JP; Hirsch MS
    N Engl J Med; 1995 Aug; 333(7):401-7. PubMed ID: 7616988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
    Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; González-Lahoz J
    N Engl J Med; 1993 Jul; 329(5):297-303. PubMed ID: 8100611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Zidovudine-resistant HIV strains in intravenous drug users and homosexual men in Amsterdam].
    de Ronde A; de Rooij ER; Coutinho RA; Goudsmit J
    Ned Tijdschr Geneeskd; 1996 Apr; 140(17):932-4. PubMed ID: 8676973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of zidovudine in HIV infection.
    Am Fam Physician; 1991 May; 43(5):1852. PubMed ID: 2021110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.